Frontiers in Neurology-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1220563, encodeId=bceb1220563fb, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：16 May 2022 Article accepted for publication.Review of Review Editor 1 finalized.Corresponding Author re-submitted manuscript.You posted new comments.You posted new comments. 09 May 2022 Review of Reviewer 4 is finalized. 05 May 2022 Interactive review forum activated automatically. 01 May 2022 Review of Reviewer 2 is finalized. 27 Apr 2022 Corresponding Author submitted manuscript. 这次审稿速度很快，20天接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cee75506658, createdName=ms8000001327218017, createdTime=Tue May 17 22:58:14 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589346, encodeId=5f3258934641, content=4.14两个审稿人都endorsed了目前final validation一周了会不会被拒啊Riverswide 2020-04-14 发表:: 3.27投稿 3.30editor assignment 当天independent review 4.8interactive review 4.11修回 4.11reviewer1 同意录用 4.13reviewer2新加了一些小意见 4.14修回目前等待中Riverswide 2020-04-14 00:00:00 发表: 3.27投稿 3.30editor assignment 当天independent review 4.8interactive review 4.11修回 4.11reviewer1 同意录用 4.13reviewer2新加了一些小意见 4.14修回目前等待中, beContent=Riverswide 2020-04-14 发表:: 3.27投稿 3.30editor assignment 当天independent review 4.8interactive review 4.11修回 4.11reviewer1 同意录用 4.13reviewer2新加了一些小意见 4.14修回目前等待中, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicNxaibzicFd3zQMibV0sw9miaRu5RAPg2QncI2aFOzIsAPqHklCxrR7nSQE8Q7wUbopkgdEQK7K7kTQ/132, createdBy=5f995124551, createdName=Riverswide, createdTime=Tue Apr 21 00:00:00 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220089, encodeId=16981220089f6, content=偏重的研究方向：脑卒中 经验分享：frontiers in neurology这个杂志，一般EA多长时间呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6cd35613068, createdName=ms1000000741572856, createdTime=Mon May 16 19:40:43 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107853, encodeId=0867210e8533e, content=大家都是几个审稿人啊，我初审时就邀请了五个审稿人，还都在一周内给了审稿意见，40条左右。我何德何能啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc9f8128107, createdName=好运常伴, createdTime=Wed Dec 28 16:33:56 CST 2022, time=2022-12-28, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2104141, encodeId=ebba210414188, content=请问一审两个审稿人评分都很低，给了大修，有可能接收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e79d8266407, createdName=ms7000000493092887, createdTime=Sat Dec 03 21:26:49 CST 2022, time=2022-12-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1239795, encodeId=801c1239e9550, content=7.6分配编辑 7.13 Reviewer 1 is finalized.5555 7.26 Reviewer 2审完以后退出审稿3222 8.18 Reviewer 3审完，提了一些问题，让修改后发表，分数3322 现在在第4个审稿人手里 这啥情况啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3b35487381, createdName=Yhao, createdTime=Fri Aug 19 19:01:00 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092229, encodeId=385a2092229ce, content=审稿速度:6.0 偏重的研究方向：脑外伤 经验分享：投稿一个半月还未找到责任编辑，慎投。同门和我同一天投的frontiers另外一个系列，已经接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52d35728563, createdName=ms2000001077628440, createdTime=Fri Oct 07 09:38:04 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091540, encodeId=97222091540bf, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：运动障碍;神经遗传;癫痫 经验分享：30 Sep 2022 Article accepted for publication. 25 Sep 2022 Review of Review Editor 3 finalized. 22 Sep 2022 re-submitted manuscript. You posted new comments. 21 Sep 2022 Reviewer 3 posted new comments. 20 Sep 2022 You posted new comments. 15 Sep 2022 Reviewer 3 posted new comments. 10 Sep 2022 re-submitted manuscript. 02 Aug 2022 submitted manuscript. 审稿人1直接拒稿，审稿人2建议修改后同意，审稿人3建议修改； 处理速度可以，比较及时，审稿意见也没有很为难，算比较顺利了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bf795518468, createdName=darkpigx, createdTime=Mon Oct 03 00:00:49 CST 2022, time=2022-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200098, encodeId=b1ef1200098b8, content=刚开始两个都同意了，修回后有一个拒，还有戏吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2fbe5639152, createdName=ms8000000759319128, createdTime=Mon Mar 07 00:18:28 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237910, encodeId=9e79123e91062, content=可以几个第一几个通讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dde62288731, createdName=121dfe5cm15暂无昵称, createdTime=Wed Aug 10 20:39:26 CST 2022, time=2022-08-10, status=1, ipAttribution=)]

2022-05-17 ms8000001327218017

审稿速度:1.0 | 投稿命中率:75.0
经验分享：16 May 2022 Article accepted for publication.Review of Review Editor 1 finalized.Corresponding Author re-submitted manuscript.You posted new comments.You posted new comments.
09 May 2022 Review of Reviewer 4 is finalized.
05 May 2022 Interactive review forum activated automatically.
01 May 2022 Review of Reviewer 2 is finalized.
27 Apr 2022 Corresponding Author submitted manuscript. 这次审稿速度很快，20天接受。

77 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=1220563, encodeId=bceb1220563fb, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：16 May 2022 Article accepted for publication.Review of Review Editor 1 finalized.Corresponding Author re-submitted manuscript.You posted new comments.You posted new comments. 09 May 2022 Review of Reviewer 4 is finalized. 05 May 2022 Interactive review forum activated automatically. 01 May 2022 Review of Reviewer 2 is finalized. 27 Apr 2022 Corresponding Author submitted manuscript. 这次审稿速度很快，20天接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cee75506658, createdName=ms8000001327218017, createdTime=Tue May 17 22:58:14 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589346, encodeId=5f3258934641, content=4.14两个审稿人都endorsed了目前final validation一周了会不会被拒啊Riverswide 2020-04-14 发表:: 3.27投稿 3.30editor assignment 当天independent review 4.8interactive review 4.11修回 4.11reviewer1 同意录用 4.13reviewer2新加了一些小意见 4.14修回目前等待中Riverswide 2020-04-14 00:00:00 发表: 3.27投稿 3.30editor assignment 当天independent review 4.8interactive review 4.11修回 4.11reviewer1 同意录用 4.13reviewer2新加了一些小意见 4.14修回目前等待中, beContent=Riverswide 2020-04-14 发表:: 3.27投稿 3.30editor assignment 当天independent review 4.8interactive review 4.11修回 4.11reviewer1 同意录用 4.13reviewer2新加了一些小意见 4.14修回目前等待中, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicNxaibzicFd3zQMibV0sw9miaRu5RAPg2QncI2aFOzIsAPqHklCxrR7nSQE8Q7wUbopkgdEQK7K7kTQ/132, createdBy=5f995124551, createdName=Riverswide, createdTime=Tue Apr 21 00:00:00 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220089, encodeId=16981220089f6, content=偏重的研究方向：脑卒中 经验分享：frontiers in neurology这个杂志，一般EA多长时间呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6cd35613068, createdName=ms1000000741572856, createdTime=Mon May 16 19:40:43 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107853, encodeId=0867210e8533e, content=大家都是几个审稿人啊，我初审时就邀请了五个审稿人，还都在一周内给了审稿意见，40条左右。我何德何能啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc9f8128107, createdName=好运常伴, createdTime=Wed Dec 28 16:33:56 CST 2022, time=2022-12-28, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2104141, encodeId=ebba210414188, content=请问一审两个审稿人评分都很低，给了大修，有可能接收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e79d8266407, createdName=ms7000000493092887, createdTime=Sat Dec 03 21:26:49 CST 2022, time=2022-12-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1239795, encodeId=801c1239e9550, content=7.6分配编辑 7.13 Reviewer 1 is finalized.5555 7.26 Reviewer 2审完以后退出审稿3222 8.18 Reviewer 3审完，提了一些问题，让修改后发表，分数3322 现在在第4个审稿人手里 这啥情况啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3b35487381, createdName=Yhao, createdTime=Fri Aug 19 19:01:00 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092229, encodeId=385a2092229ce, content=审稿速度:6.0 偏重的研究方向：脑外伤 经验分享：投稿一个半月还未找到责任编辑，慎投。同门和我同一天投的frontiers另外一个系列，已经接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52d35728563, createdName=ms2000001077628440, createdTime=Fri Oct 07 09:38:04 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091540, encodeId=97222091540bf, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：运动障碍;神经遗传;癫痫 经验分享：30 Sep 2022 Article accepted for publication. 25 Sep 2022 Review of Review Editor 3 finalized. 22 Sep 2022 re-submitted manuscript. You posted new comments. 21 Sep 2022 Reviewer 3 posted new comments. 20 Sep 2022 You posted new comments. 15 Sep 2022 Reviewer 3 posted new comments. 10 Sep 2022 re-submitted manuscript. 02 Aug 2022 submitted manuscript. 审稿人1直接拒稿，审稿人2建议修改后同意，审稿人3建议修改； 处理速度可以，比较及时，审稿意见也没有很为难，算比较顺利了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bf795518468, createdName=darkpigx, createdTime=Mon Oct 03 00:00:49 CST 2022, time=2022-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200098, encodeId=b1ef1200098b8, content=刚开始两个都同意了，修回后有一个拒，还有戏吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2fbe5639152, createdName=ms8000000759319128, createdTime=Mon Mar 07 00:18:28 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237910, encodeId=9e79123e91062, content=可以几个第一几个通讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dde62288731, createdName=121dfe5cm15暂无昵称, createdTime=Wed Aug 10 20:39:26 CST 2022, time=2022-08-10, status=1, ipAttribution=)]

2020-04-21 Riverswide

4.14两个审稿人都endorsed了目前final validation一周了会不会被拒啊Riverswide 2020-04-14 发表::
3.27投稿 3.30editor assignment 当天independent review 4.8interactive review 4.11修回 4.11reviewer1 同意录用 4.13reviewer2新加了一些小意见 4.14修回目前等待中Riverswide 2020-04-14 00:00:00 发表:
3.27投稿 3.30editor assignment 当天independent review 4.8interactive review 4.11修回 4.11reviewer1 同意录用 4.13reviewer2新加了一些小意见 4.14修回目前等待中

Riverswide 2020-04-14 发表:: 3.27投稿 3.30editor assignment 当天independent review 4.8interactive review 4.11修回 4.11reviewer1 同意录用 4.13reviewer2新加了一些小意见 4.14修回目前等待中

129 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1220563, encodeId=bceb1220563fb, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：16 May 2022 Article accepted for publication.Review of Review Editor 1 finalized.Corresponding Author re-submitted manuscript.You posted new comments.You posted new comments. 09 May 2022 Review of Reviewer 4 is finalized. 05 May 2022 Interactive review forum activated automatically. 01 May 2022 Review of Reviewer 2 is finalized. 27 Apr 2022 Corresponding Author submitted manuscript. 这次审稿速度很快，20天接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cee75506658, createdName=ms8000001327218017, createdTime=Tue May 17 22:58:14 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589346, encodeId=5f3258934641, content=4.14两个审稿人都endorsed了目前final validation一周了会不会被拒啊Riverswide 2020-04-14 发表:: 3.27投稿 3.30editor assignment 当天independent review 4.8interactive review 4.11修回 4.11reviewer1 同意录用 4.13reviewer2新加了一些小意见 4.14修回目前等待中Riverswide 2020-04-14 00:00:00 发表: 3.27投稿 3.30editor assignment 当天independent review 4.8interactive review 4.11修回 4.11reviewer1 同意录用 4.13reviewer2新加了一些小意见 4.14修回目前等待中, beContent=Riverswide 2020-04-14 发表:: 3.27投稿 3.30editor assignment 当天independent review 4.8interactive review 4.11修回 4.11reviewer1 同意录用 4.13reviewer2新加了一些小意见 4.14修回目前等待中, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicNxaibzicFd3zQMibV0sw9miaRu5RAPg2QncI2aFOzIsAPqHklCxrR7nSQE8Q7wUbopkgdEQK7K7kTQ/132, createdBy=5f995124551, createdName=Riverswide, createdTime=Tue Apr 21 00:00:00 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220089, encodeId=16981220089f6, content=偏重的研究方向：脑卒中 经验分享：frontiers in neurology这个杂志，一般EA多长时间呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6cd35613068, createdName=ms1000000741572856, createdTime=Mon May 16 19:40:43 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107853, encodeId=0867210e8533e, content=大家都是几个审稿人啊，我初审时就邀请了五个审稿人，还都在一周内给了审稿意见，40条左右。我何德何能啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc9f8128107, createdName=好运常伴, createdTime=Wed Dec 28 16:33:56 CST 2022, time=2022-12-28, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2104141, encodeId=ebba210414188, content=请问一审两个审稿人评分都很低，给了大修，有可能接收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e79d8266407, createdName=ms7000000493092887, createdTime=Sat Dec 03 21:26:49 CST 2022, time=2022-12-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1239795, encodeId=801c1239e9550, content=7.6分配编辑 7.13 Reviewer 1 is finalized.5555 7.26 Reviewer 2审完以后退出审稿3222 8.18 Reviewer 3审完，提了一些问题，让修改后发表，分数3322 现在在第4个审稿人手里 这啥情况啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3b35487381, createdName=Yhao, createdTime=Fri Aug 19 19:01:00 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092229, encodeId=385a2092229ce, content=审稿速度:6.0 偏重的研究方向：脑外伤 经验分享：投稿一个半月还未找到责任编辑，慎投。同门和我同一天投的frontiers另外一个系列，已经接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52d35728563, createdName=ms2000001077628440, createdTime=Fri Oct 07 09:38:04 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091540, encodeId=97222091540bf, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：运动障碍;神经遗传;癫痫 经验分享：30 Sep 2022 Article accepted for publication. 25 Sep 2022 Review of Review Editor 3 finalized. 22 Sep 2022 re-submitted manuscript. You posted new comments. 21 Sep 2022 Reviewer 3 posted new comments. 20 Sep 2022 You posted new comments. 15 Sep 2022 Reviewer 3 posted new comments. 10 Sep 2022 re-submitted manuscript. 02 Aug 2022 submitted manuscript. 审稿人1直接拒稿，审稿人2建议修改后同意，审稿人3建议修改； 处理速度可以，比较及时，审稿意见也没有很为难，算比较顺利了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bf795518468, createdName=darkpigx, createdTime=Mon Oct 03 00:00:49 CST 2022, time=2022-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200098, encodeId=b1ef1200098b8, content=刚开始两个都同意了，修回后有一个拒，还有戏吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2fbe5639152, createdName=ms8000000759319128, createdTime=Mon Mar 07 00:18:28 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237910, encodeId=9e79123e91062, content=可以几个第一几个通讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dde62288731, createdName=121dfe5cm15暂无昵称, createdTime=Wed Aug 10 20:39:26 CST 2022, time=2022-08-10, status=1, ipAttribution=)]

2022-05-16 ms1000000741572856

偏重的研究方向：脑卒中
经验分享：frontiers in neurology这个杂志，一般EA多长时间呢？

52 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1220563, encodeId=bceb1220563fb, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：16 May 2022 Article accepted for publication.Review of Review Editor 1 finalized.Corresponding Author re-submitted manuscript.You posted new comments.You posted new comments. 09 May 2022 Review of Reviewer 4 is finalized. 05 May 2022 Interactive review forum activated automatically. 01 May 2022 Review of Reviewer 2 is finalized. 27 Apr 2022 Corresponding Author submitted manuscript. 这次审稿速度很快，20天接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cee75506658, createdName=ms8000001327218017, createdTime=Tue May 17 22:58:14 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589346, encodeId=5f3258934641, content=4.14两个审稿人都endorsed了目前final validation一周了会不会被拒啊Riverswide 2020-04-14 发表:: 3.27投稿 3.30editor assignment 当天independent review 4.8interactive review 4.11修回 4.11reviewer1 同意录用 4.13reviewer2新加了一些小意见 4.14修回目前等待中Riverswide 2020-04-14 00:00:00 发表: 3.27投稿 3.30editor assignment 当天independent review 4.8interactive review 4.11修回 4.11reviewer1 同意录用 4.13reviewer2新加了一些小意见 4.14修回目前等待中, beContent=Riverswide 2020-04-14 发表:: 3.27投稿 3.30editor assignment 当天independent review 4.8interactive review 4.11修回 4.11reviewer1 同意录用 4.13reviewer2新加了一些小意见 4.14修回目前等待中, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicNxaibzicFd3zQMibV0sw9miaRu5RAPg2QncI2aFOzIsAPqHklCxrR7nSQE8Q7wUbopkgdEQK7K7kTQ/132, createdBy=5f995124551, createdName=Riverswide, createdTime=Tue Apr 21 00:00:00 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220089, encodeId=16981220089f6, content=偏重的研究方向：脑卒中 经验分享：frontiers in neurology这个杂志，一般EA多长时间呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6cd35613068, createdName=ms1000000741572856, createdTime=Mon May 16 19:40:43 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107853, encodeId=0867210e8533e, content=大家都是几个审稿人啊，我初审时就邀请了五个审稿人，还都在一周内给了审稿意见，40条左右。我何德何能啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc9f8128107, createdName=好运常伴, createdTime=Wed Dec 28 16:33:56 CST 2022, time=2022-12-28, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2104141, encodeId=ebba210414188, content=请问一审两个审稿人评分都很低，给了大修，有可能接收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e79d8266407, createdName=ms7000000493092887, createdTime=Sat Dec 03 21:26:49 CST 2022, time=2022-12-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1239795, encodeId=801c1239e9550, content=7.6分配编辑 7.13 Reviewer 1 is finalized.5555 7.26 Reviewer 2审完以后退出审稿3222 8.18 Reviewer 3审完，提了一些问题，让修改后发表，分数3322 现在在第4个审稿人手里 这啥情况啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3b35487381, createdName=Yhao, createdTime=Fri Aug 19 19:01:00 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092229, encodeId=385a2092229ce, content=审稿速度:6.0 偏重的研究方向：脑外伤 经验分享：投稿一个半月还未找到责任编辑，慎投。同门和我同一天投的frontiers另外一个系列，已经接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52d35728563, createdName=ms2000001077628440, createdTime=Fri Oct 07 09:38:04 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091540, encodeId=97222091540bf, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：运动障碍;神经遗传;癫痫 经验分享：30 Sep 2022 Article accepted for publication. 25 Sep 2022 Review of Review Editor 3 finalized. 22 Sep 2022 re-submitted manuscript. You posted new comments. 21 Sep 2022 Reviewer 3 posted new comments. 20 Sep 2022 You posted new comments. 15 Sep 2022 Reviewer 3 posted new comments. 10 Sep 2022 re-submitted manuscript. 02 Aug 2022 submitted manuscript. 审稿人1直接拒稿，审稿人2建议修改后同意，审稿人3建议修改； 处理速度可以，比较及时，审稿意见也没有很为难，算比较顺利了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bf795518468, createdName=darkpigx, createdTime=Mon Oct 03 00:00:49 CST 2022, time=2022-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200098, encodeId=b1ef1200098b8, content=刚开始两个都同意了，修回后有一个拒，还有戏吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2fbe5639152, createdName=ms8000000759319128, createdTime=Mon Mar 07 00:18:28 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237910, encodeId=9e79123e91062, content=可以几个第一几个通讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dde62288731, createdName=121dfe5cm15暂无昵称, createdTime=Wed Aug 10 20:39:26 CST 2022, time=2022-08-10, status=1, ipAttribution=)]

2022-12-28 好运常伴来自山西省

大家都是几个审稿人啊，我初审时就邀请了五个审稿人，还都在一周内给了审稿意见，40条左右。我何德何能啊

48 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1220563, encodeId=bceb1220563fb, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：16 May 2022 Article accepted for publication.Review of Review Editor 1 finalized.Corresponding Author re-submitted manuscript.You posted new comments.You posted new comments. 09 May 2022 Review of Reviewer 4 is finalized. 05 May 2022 Interactive review forum activated automatically. 01 May 2022 Review of Reviewer 2 is finalized. 27 Apr 2022 Corresponding Author submitted manuscript. 这次审稿速度很快，20天接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cee75506658, createdName=ms8000001327218017, createdTime=Tue May 17 22:58:14 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589346, encodeId=5f3258934641, content=4.14两个审稿人都endorsed了目前final validation一周了会不会被拒啊Riverswide 2020-04-14 发表:: 3.27投稿 3.30editor assignment 当天independent review 4.8interactive review 4.11修回 4.11reviewer1 同意录用 4.13reviewer2新加了一些小意见 4.14修回目前等待中Riverswide 2020-04-14 00:00:00 发表: 3.27投稿 3.30editor assignment 当天independent review 4.8interactive review 4.11修回 4.11reviewer1 同意录用 4.13reviewer2新加了一些小意见 4.14修回目前等待中, beContent=Riverswide 2020-04-14 发表:: 3.27投稿 3.30editor assignment 当天independent review 4.8interactive review 4.11修回 4.11reviewer1 同意录用 4.13reviewer2新加了一些小意见 4.14修回目前等待中, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicNxaibzicFd3zQMibV0sw9miaRu5RAPg2QncI2aFOzIsAPqHklCxrR7nSQE8Q7wUbopkgdEQK7K7kTQ/132, createdBy=5f995124551, createdName=Riverswide, createdTime=Tue Apr 21 00:00:00 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220089, encodeId=16981220089f6, content=偏重的研究方向：脑卒中 经验分享：frontiers in neurology这个杂志，一般EA多长时间呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6cd35613068, createdName=ms1000000741572856, createdTime=Mon May 16 19:40:43 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107853, encodeId=0867210e8533e, content=大家都是几个审稿人啊，我初审时就邀请了五个审稿人，还都在一周内给了审稿意见，40条左右。我何德何能啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc9f8128107, createdName=好运常伴, createdTime=Wed Dec 28 16:33:56 CST 2022, time=2022-12-28, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2104141, encodeId=ebba210414188, content=请问一审两个审稿人评分都很低，给了大修，有可能接收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e79d8266407, createdName=ms7000000493092887, createdTime=Sat Dec 03 21:26:49 CST 2022, time=2022-12-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1239795, encodeId=801c1239e9550, content=7.6分配编辑 7.13 Reviewer 1 is finalized.5555 7.26 Reviewer 2审完以后退出审稿3222 8.18 Reviewer 3审完，提了一些问题，让修改后发表，分数3322 现在在第4个审稿人手里 这啥情况啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3b35487381, createdName=Yhao, createdTime=Fri Aug 19 19:01:00 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092229, encodeId=385a2092229ce, content=审稿速度:6.0 偏重的研究方向：脑外伤 经验分享：投稿一个半月还未找到责任编辑，慎投。同门和我同一天投的frontiers另外一个系列，已经接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52d35728563, createdName=ms2000001077628440, createdTime=Fri Oct 07 09:38:04 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091540, encodeId=97222091540bf, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：运动障碍;神经遗传;癫痫 经验分享：30 Sep 2022 Article accepted for publication. 25 Sep 2022 Review of Review Editor 3 finalized. 22 Sep 2022 re-submitted manuscript. You posted new comments. 21 Sep 2022 Reviewer 3 posted new comments. 20 Sep 2022 You posted new comments. 15 Sep 2022 Reviewer 3 posted new comments. 10 Sep 2022 re-submitted manuscript. 02 Aug 2022 submitted manuscript. 审稿人1直接拒稿，审稿人2建议修改后同意，审稿人3建议修改； 处理速度可以，比较及时，审稿意见也没有很为难，算比较顺利了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bf795518468, createdName=darkpigx, createdTime=Mon Oct 03 00:00:49 CST 2022, time=2022-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200098, encodeId=b1ef1200098b8, content=刚开始两个都同意了，修回后有一个拒，还有戏吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2fbe5639152, createdName=ms8000000759319128, createdTime=Mon Mar 07 00:18:28 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237910, encodeId=9e79123e91062, content=可以几个第一几个通讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dde62288731, createdName=121dfe5cm15暂无昵称, createdTime=Wed Aug 10 20:39:26 CST 2022, time=2022-08-10, status=1, ipAttribution=)]

2022-12-03 ms7000000493092887 来自江苏省

请问一审两个审稿人评分都很低，给了大修，有可能接收吗？

43 0

[GetPortalCommentsPageByObjectIdResponse(id=1220563, encodeId=bceb1220563fb, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：16 May 2022 Article accepted for publication.Review of Review Editor 1 finalized.Corresponding Author re-submitted manuscript.You posted new comments.You posted new comments. 09 May 2022 Review of Reviewer 4 is finalized. 05 May 2022 Interactive review forum activated automatically. 01 May 2022 Review of Reviewer 2 is finalized. 27 Apr 2022 Corresponding Author submitted manuscript. 这次审稿速度很快，20天接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cee75506658, createdName=ms8000001327218017, createdTime=Tue May 17 22:58:14 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589346, encodeId=5f3258934641, content=4.14两个审稿人都endorsed了目前final validation一周了会不会被拒啊Riverswide 2020-04-14 发表:: 3.27投稿 3.30editor assignment 当天independent review 4.8interactive review 4.11修回 4.11reviewer1 同意录用 4.13reviewer2新加了一些小意见 4.14修回目前等待中Riverswide 2020-04-14 00:00:00 发表: 3.27投稿 3.30editor assignment 当天independent review 4.8interactive review 4.11修回 4.11reviewer1 同意录用 4.13reviewer2新加了一些小意见 4.14修回目前等待中, beContent=Riverswide 2020-04-14 发表:: 3.27投稿 3.30editor assignment 当天independent review 4.8interactive review 4.11修回 4.11reviewer1 同意录用 4.13reviewer2新加了一些小意见 4.14修回目前等待中, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicNxaibzicFd3zQMibV0sw9miaRu5RAPg2QncI2aFOzIsAPqHklCxrR7nSQE8Q7wUbopkgdEQK7K7kTQ/132, createdBy=5f995124551, createdName=Riverswide, createdTime=Tue Apr 21 00:00:00 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220089, encodeId=16981220089f6, content=偏重的研究方向：脑卒中 经验分享：frontiers in neurology这个杂志，一般EA多长时间呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6cd35613068, createdName=ms1000000741572856, createdTime=Mon May 16 19:40:43 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107853, encodeId=0867210e8533e, content=大家都是几个审稿人啊，我初审时就邀请了五个审稿人，还都在一周内给了审稿意见，40条左右。我何德何能啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc9f8128107, createdName=好运常伴, createdTime=Wed Dec 28 16:33:56 CST 2022, time=2022-12-28, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2104141, encodeId=ebba210414188, content=请问一审两个审稿人评分都很低，给了大修，有可能接收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e79d8266407, createdName=ms7000000493092887, createdTime=Sat Dec 03 21:26:49 CST 2022, time=2022-12-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1239795, encodeId=801c1239e9550, content=7.6分配编辑 7.13 Reviewer 1 is finalized.5555 7.26 Reviewer 2审完以后退出审稿3222 8.18 Reviewer 3审完，提了一些问题，让修改后发表，分数3322 现在在第4个审稿人手里 这啥情况啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3b35487381, createdName=Yhao, createdTime=Fri Aug 19 19:01:00 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092229, encodeId=385a2092229ce, content=审稿速度:6.0 偏重的研究方向：脑外伤 经验分享：投稿一个半月还未找到责任编辑，慎投。同门和我同一天投的frontiers另外一个系列，已经接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52d35728563, createdName=ms2000001077628440, createdTime=Fri Oct 07 09:38:04 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091540, encodeId=97222091540bf, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：运动障碍;神经遗传;癫痫 经验分享：30 Sep 2022 Article accepted for publication. 25 Sep 2022 Review of Review Editor 3 finalized. 22 Sep 2022 re-submitted manuscript. You posted new comments. 21 Sep 2022 Reviewer 3 posted new comments. 20 Sep 2022 You posted new comments. 15 Sep 2022 Reviewer 3 posted new comments. 10 Sep 2022 re-submitted manuscript. 02 Aug 2022 submitted manuscript. 审稿人1直接拒稿，审稿人2建议修改后同意，审稿人3建议修改； 处理速度可以，比较及时，审稿意见也没有很为难，算比较顺利了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bf795518468, createdName=darkpigx, createdTime=Mon Oct 03 00:00:49 CST 2022, time=2022-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200098, encodeId=b1ef1200098b8, content=刚开始两个都同意了，修回后有一个拒，还有戏吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2fbe5639152, createdName=ms8000000759319128, createdTime=Mon Mar 07 00:18:28 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237910, encodeId=9e79123e91062, content=可以几个第一几个通讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dde62288731, createdName=121dfe5cm15暂无昵称, createdTime=Wed Aug 10 20:39:26 CST 2022, time=2022-08-10, status=1, ipAttribution=)]

2022-08-19 Yhao

7.6分配编辑
7.13 Reviewer 1 is finalized.5555
7.26 Reviewer 2审完以后退出审稿3222
8.18 Reviewer 3审完，提了一些问题，让修改后发表，分数3322
现在在第4个审稿人手里
这啥情况啊？

64 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=1220563, encodeId=bceb1220563fb, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：16 May 2022 Article accepted for publication.Review of Review Editor 1 finalized.Corresponding Author re-submitted manuscript.You posted new comments.You posted new comments. 09 May 2022 Review of Reviewer 4 is finalized. 05 May 2022 Interactive review forum activated automatically. 01 May 2022 Review of Reviewer 2 is finalized. 27 Apr 2022 Corresponding Author submitted manuscript. 这次审稿速度很快，20天接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cee75506658, createdName=ms8000001327218017, createdTime=Tue May 17 22:58:14 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589346, encodeId=5f3258934641, content=4.14两个审稿人都endorsed了目前final validation一周了会不会被拒啊Riverswide 2020-04-14 发表:: 3.27投稿 3.30editor assignment 当天independent review 4.8interactive review 4.11修回 4.11reviewer1 同意录用 4.13reviewer2新加了一些小意见 4.14修回目前等待中Riverswide 2020-04-14 00:00:00 发表: 3.27投稿 3.30editor assignment 当天independent review 4.8interactive review 4.11修回 4.11reviewer1 同意录用 4.13reviewer2新加了一些小意见 4.14修回目前等待中, beContent=Riverswide 2020-04-14 发表:: 3.27投稿 3.30editor assignment 当天independent review 4.8interactive review 4.11修回 4.11reviewer1 同意录用 4.13reviewer2新加了一些小意见 4.14修回目前等待中, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicNxaibzicFd3zQMibV0sw9miaRu5RAPg2QncI2aFOzIsAPqHklCxrR7nSQE8Q7wUbopkgdEQK7K7kTQ/132, createdBy=5f995124551, createdName=Riverswide, createdTime=Tue Apr 21 00:00:00 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220089, encodeId=16981220089f6, content=偏重的研究方向：脑卒中 经验分享：frontiers in neurology这个杂志，一般EA多长时间呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6cd35613068, createdName=ms1000000741572856, createdTime=Mon May 16 19:40:43 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107853, encodeId=0867210e8533e, content=大家都是几个审稿人啊，我初审时就邀请了五个审稿人，还都在一周内给了审稿意见，40条左右。我何德何能啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc9f8128107, createdName=好运常伴, createdTime=Wed Dec 28 16:33:56 CST 2022, time=2022-12-28, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2104141, encodeId=ebba210414188, content=请问一审两个审稿人评分都很低，给了大修，有可能接收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e79d8266407, createdName=ms7000000493092887, createdTime=Sat Dec 03 21:26:49 CST 2022, time=2022-12-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1239795, encodeId=801c1239e9550, content=7.6分配编辑 7.13 Reviewer 1 is finalized.5555 7.26 Reviewer 2审完以后退出审稿3222 8.18 Reviewer 3审完，提了一些问题，让修改后发表，分数3322 现在在第4个审稿人手里 这啥情况啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3b35487381, createdName=Yhao, createdTime=Fri Aug 19 19:01:00 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092229, encodeId=385a2092229ce, content=审稿速度:6.0 偏重的研究方向：脑外伤 经验分享：投稿一个半月还未找到责任编辑，慎投。同门和我同一天投的frontiers另外一个系列，已经接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52d35728563, createdName=ms2000001077628440, createdTime=Fri Oct 07 09:38:04 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091540, encodeId=97222091540bf, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：运动障碍;神经遗传;癫痫 经验分享：30 Sep 2022 Article accepted for publication. 25 Sep 2022 Review of Review Editor 3 finalized. 22 Sep 2022 re-submitted manuscript. You posted new comments. 21 Sep 2022 Reviewer 3 posted new comments. 20 Sep 2022 You posted new comments. 15 Sep 2022 Reviewer 3 posted new comments. 10 Sep 2022 re-submitted manuscript. 02 Aug 2022 submitted manuscript. 审稿人1直接拒稿，审稿人2建议修改后同意，审稿人3建议修改； 处理速度可以，比较及时，审稿意见也没有很为难，算比较顺利了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bf795518468, createdName=darkpigx, createdTime=Mon Oct 03 00:00:49 CST 2022, time=2022-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200098, encodeId=b1ef1200098b8, content=刚开始两个都同意了，修回后有一个拒，还有戏吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2fbe5639152, createdName=ms8000000759319128, createdTime=Mon Mar 07 00:18:28 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237910, encodeId=9e79123e91062, content=可以几个第一几个通讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dde62288731, createdName=121dfe5cm15暂无昵称, createdTime=Wed Aug 10 20:39:26 CST 2022, time=2022-08-10, status=1, ipAttribution=)]

2022-10-07 ms2000001077628440

审稿速度:6.0
偏重的研究方向：脑外伤
经验分享：投稿一个半月还未找到责任编辑，慎投。同门和我同一天投的frontiers另外一个系列，已经接收。

46 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1220563, encodeId=bceb1220563fb, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：16 May 2022 Article accepted for publication.Review of Review Editor 1 finalized.Corresponding Author re-submitted manuscript.You posted new comments.You posted new comments. 09 May 2022 Review of Reviewer 4 is finalized. 05 May 2022 Interactive review forum activated automatically. 01 May 2022 Review of Reviewer 2 is finalized. 27 Apr 2022 Corresponding Author submitted manuscript. 这次审稿速度很快，20天接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cee75506658, createdName=ms8000001327218017, createdTime=Tue May 17 22:58:14 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589346, encodeId=5f3258934641, content=4.14两个审稿人都endorsed了目前final validation一周了会不会被拒啊Riverswide 2020-04-14 发表:: 3.27投稿 3.30editor assignment 当天independent review 4.8interactive review 4.11修回 4.11reviewer1 同意录用 4.13reviewer2新加了一些小意见 4.14修回目前等待中Riverswide 2020-04-14 00:00:00 发表: 3.27投稿 3.30editor assignment 当天independent review 4.8interactive review 4.11修回 4.11reviewer1 同意录用 4.13reviewer2新加了一些小意见 4.14修回目前等待中, beContent=Riverswide 2020-04-14 发表:: 3.27投稿 3.30editor assignment 当天independent review 4.8interactive review 4.11修回 4.11reviewer1 同意录用 4.13reviewer2新加了一些小意见 4.14修回目前等待中, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicNxaibzicFd3zQMibV0sw9miaRu5RAPg2QncI2aFOzIsAPqHklCxrR7nSQE8Q7wUbopkgdEQK7K7kTQ/132, createdBy=5f995124551, createdName=Riverswide, createdTime=Tue Apr 21 00:00:00 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220089, encodeId=16981220089f6, content=偏重的研究方向：脑卒中 经验分享：frontiers in neurology这个杂志，一般EA多长时间呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6cd35613068, createdName=ms1000000741572856, createdTime=Mon May 16 19:40:43 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107853, encodeId=0867210e8533e, content=大家都是几个审稿人啊，我初审时就邀请了五个审稿人，还都在一周内给了审稿意见，40条左右。我何德何能啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc9f8128107, createdName=好运常伴, createdTime=Wed Dec 28 16:33:56 CST 2022, time=2022-12-28, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2104141, encodeId=ebba210414188, content=请问一审两个审稿人评分都很低，给了大修，有可能接收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e79d8266407, createdName=ms7000000493092887, createdTime=Sat Dec 03 21:26:49 CST 2022, time=2022-12-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1239795, encodeId=801c1239e9550, content=7.6分配编辑 7.13 Reviewer 1 is finalized.5555 7.26 Reviewer 2审完以后退出审稿3222 8.18 Reviewer 3审完，提了一些问题，让修改后发表，分数3322 现在在第4个审稿人手里 这啥情况啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3b35487381, createdName=Yhao, createdTime=Fri Aug 19 19:01:00 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092229, encodeId=385a2092229ce, content=审稿速度:6.0 偏重的研究方向：脑外伤 经验分享：投稿一个半月还未找到责任编辑，慎投。同门和我同一天投的frontiers另外一个系列，已经接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52d35728563, createdName=ms2000001077628440, createdTime=Fri Oct 07 09:38:04 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091540, encodeId=97222091540bf, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：运动障碍;神经遗传;癫痫 经验分享：30 Sep 2022 Article accepted for publication. 25 Sep 2022 Review of Review Editor 3 finalized. 22 Sep 2022 re-submitted manuscript. You posted new comments. 21 Sep 2022 Reviewer 3 posted new comments. 20 Sep 2022 You posted new comments. 15 Sep 2022 Reviewer 3 posted new comments. 10 Sep 2022 re-submitted manuscript. 02 Aug 2022 submitted manuscript. 审稿人1直接拒稿，审稿人2建议修改后同意，审稿人3建议修改； 处理速度可以，比较及时，审稿意见也没有很为难，算比较顺利了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bf795518468, createdName=darkpigx, createdTime=Mon Oct 03 00:00:49 CST 2022, time=2022-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200098, encodeId=b1ef1200098b8, content=刚开始两个都同意了，修回后有一个拒，还有戏吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2fbe5639152, createdName=ms8000000759319128, createdTime=Mon Mar 07 00:18:28 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237910, encodeId=9e79123e91062, content=可以几个第一几个通讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dde62288731, createdName=121dfe5cm15暂无昵称, createdTime=Wed Aug 10 20:39:26 CST 2022, time=2022-08-10, status=1, ipAttribution=)]

2022-10-03 darkpigx

审稿速度:2.0 | 投稿命中率:75.0
偏重的研究方向：运动障碍;神经遗传;癫痫
经验分享：30 Sep 2022 Article accepted for publication.
25 Sep 2022 Review of Review Editor 3 finalized.
22 Sep 2022 re-submitted manuscript. You posted new comments.
21 Sep 2022 Reviewer 3 posted new comments.
20 Sep 2022 You posted new comments.
15 Sep 2022 Reviewer 3 posted new comments.
10 Sep 2022 re-submitted manuscript.
02 Aug 2022 submitted manuscript.

审稿人1直接拒稿，审稿人2建议修改后同意，审稿人3建议修改；
处理速度可以，比较及时，审稿意见也没有很为难，算比较顺利了

41 0

[GetPortalCommentsPageByObjectIdResponse(id=1220563, encodeId=bceb1220563fb, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：16 May 2022 Article accepted for publication.Review of Review Editor 1 finalized.Corresponding Author re-submitted manuscript.You posted new comments.You posted new comments. 09 May 2022 Review of Reviewer 4 is finalized. 05 May 2022 Interactive review forum activated automatically. 01 May 2022 Review of Reviewer 2 is finalized. 27 Apr 2022 Corresponding Author submitted manuscript. 这次审稿速度很快，20天接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cee75506658, createdName=ms8000001327218017, createdTime=Tue May 17 22:58:14 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589346, encodeId=5f3258934641, content=4.14两个审稿人都endorsed了目前final validation一周了会不会被拒啊Riverswide 2020-04-14 发表:: 3.27投稿 3.30editor assignment 当天independent review 4.8interactive review 4.11修回 4.11reviewer1 同意录用 4.13reviewer2新加了一些小意见 4.14修回目前等待中Riverswide 2020-04-14 00:00:00 发表: 3.27投稿 3.30editor assignment 当天independent review 4.8interactive review 4.11修回 4.11reviewer1 同意录用 4.13reviewer2新加了一些小意见 4.14修回目前等待中, beContent=Riverswide 2020-04-14 发表:: 3.27投稿 3.30editor assignment 当天independent review 4.8interactive review 4.11修回 4.11reviewer1 同意录用 4.13reviewer2新加了一些小意见 4.14修回目前等待中, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicNxaibzicFd3zQMibV0sw9miaRu5RAPg2QncI2aFOzIsAPqHklCxrR7nSQE8Q7wUbopkgdEQK7K7kTQ/132, createdBy=5f995124551, createdName=Riverswide, createdTime=Tue Apr 21 00:00:00 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220089, encodeId=16981220089f6, content=偏重的研究方向：脑卒中 经验分享：frontiers in neurology这个杂志，一般EA多长时间呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6cd35613068, createdName=ms1000000741572856, createdTime=Mon May 16 19:40:43 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107853, encodeId=0867210e8533e, content=大家都是几个审稿人啊，我初审时就邀请了五个审稿人，还都在一周内给了审稿意见，40条左右。我何德何能啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc9f8128107, createdName=好运常伴, createdTime=Wed Dec 28 16:33:56 CST 2022, time=2022-12-28, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2104141, encodeId=ebba210414188, content=请问一审两个审稿人评分都很低，给了大修，有可能接收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e79d8266407, createdName=ms7000000493092887, createdTime=Sat Dec 03 21:26:49 CST 2022, time=2022-12-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1239795, encodeId=801c1239e9550, content=7.6分配编辑 7.13 Reviewer 1 is finalized.5555 7.26 Reviewer 2审完以后退出审稿3222 8.18 Reviewer 3审完，提了一些问题，让修改后发表，分数3322 现在在第4个审稿人手里 这啥情况啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3b35487381, createdName=Yhao, createdTime=Fri Aug 19 19:01:00 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092229, encodeId=385a2092229ce, content=审稿速度:6.0 偏重的研究方向：脑外伤 经验分享：投稿一个半月还未找到责任编辑，慎投。同门和我同一天投的frontiers另外一个系列，已经接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52d35728563, createdName=ms2000001077628440, createdTime=Fri Oct 07 09:38:04 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091540, encodeId=97222091540bf, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：运动障碍;神经遗传;癫痫 经验分享：30 Sep 2022 Article accepted for publication. 25 Sep 2022 Review of Review Editor 3 finalized. 22 Sep 2022 re-submitted manuscript. You posted new comments. 21 Sep 2022 Reviewer 3 posted new comments. 20 Sep 2022 You posted new comments. 15 Sep 2022 Reviewer 3 posted new comments. 10 Sep 2022 re-submitted manuscript. 02 Aug 2022 submitted manuscript. 审稿人1直接拒稿，审稿人2建议修改后同意，审稿人3建议修改； 处理速度可以，比较及时，审稿意见也没有很为难，算比较顺利了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bf795518468, createdName=darkpigx, createdTime=Mon Oct 03 00:00:49 CST 2022, time=2022-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200098, encodeId=b1ef1200098b8, content=刚开始两个都同意了，修回后有一个拒，还有戏吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2fbe5639152, createdName=ms8000000759319128, createdTime=Mon Mar 07 00:18:28 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237910, encodeId=9e79123e91062, content=可以几个第一几个通讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dde62288731, createdName=121dfe5cm15暂无昵称, createdTime=Wed Aug 10 20:39:26 CST 2022, time=2022-08-10, status=1, ipAttribution=)]

2022-03-07 ms8000000759319128

刚开始两个都同意了，修回后有一个拒，还有戏吗

44 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1220563, encodeId=bceb1220563fb, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：16 May 2022 Article accepted for publication.Review of Review Editor 1 finalized.Corresponding Author re-submitted manuscript.You posted new comments.You posted new comments. 09 May 2022 Review of Reviewer 4 is finalized. 05 May 2022 Interactive review forum activated automatically. 01 May 2022 Review of Reviewer 2 is finalized. 27 Apr 2022 Corresponding Author submitted manuscript. 这次审稿速度很快，20天接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cee75506658, createdName=ms8000001327218017, createdTime=Tue May 17 22:58:14 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589346, encodeId=5f3258934641, content=4.14两个审稿人都endorsed了目前final validation一周了会不会被拒啊Riverswide 2020-04-14 发表:: 3.27投稿 3.30editor assignment 当天independent review 4.8interactive review 4.11修回 4.11reviewer1 同意录用 4.13reviewer2新加了一些小意见 4.14修回目前等待中Riverswide 2020-04-14 00:00:00 发表: 3.27投稿 3.30editor assignment 当天independent review 4.8interactive review 4.11修回 4.11reviewer1 同意录用 4.13reviewer2新加了一些小意见 4.14修回目前等待中, beContent=Riverswide 2020-04-14 发表:: 3.27投稿 3.30editor assignment 当天independent review 4.8interactive review 4.11修回 4.11reviewer1 同意录用 4.13reviewer2新加了一些小意见 4.14修回目前等待中, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicNxaibzicFd3zQMibV0sw9miaRu5RAPg2QncI2aFOzIsAPqHklCxrR7nSQE8Q7wUbopkgdEQK7K7kTQ/132, createdBy=5f995124551, createdName=Riverswide, createdTime=Tue Apr 21 00:00:00 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220089, encodeId=16981220089f6, content=偏重的研究方向：脑卒中 经验分享：frontiers in neurology这个杂志，一般EA多长时间呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6cd35613068, createdName=ms1000000741572856, createdTime=Mon May 16 19:40:43 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107853, encodeId=0867210e8533e, content=大家都是几个审稿人啊，我初审时就邀请了五个审稿人，还都在一周内给了审稿意见，40条左右。我何德何能啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc9f8128107, createdName=好运常伴, createdTime=Wed Dec 28 16:33:56 CST 2022, time=2022-12-28, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2104141, encodeId=ebba210414188, content=请问一审两个审稿人评分都很低，给了大修，有可能接收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e79d8266407, createdName=ms7000000493092887, createdTime=Sat Dec 03 21:26:49 CST 2022, time=2022-12-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1239795, encodeId=801c1239e9550, content=7.6分配编辑 7.13 Reviewer 1 is finalized.5555 7.26 Reviewer 2审完以后退出审稿3222 8.18 Reviewer 3审完，提了一些问题，让修改后发表，分数3322 现在在第4个审稿人手里 这啥情况啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3b35487381, createdName=Yhao, createdTime=Fri Aug 19 19:01:00 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092229, encodeId=385a2092229ce, content=审稿速度:6.0 偏重的研究方向：脑外伤 经验分享：投稿一个半月还未找到责任编辑，慎投。同门和我同一天投的frontiers另外一个系列，已经接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52d35728563, createdName=ms2000001077628440, createdTime=Fri Oct 07 09:38:04 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091540, encodeId=97222091540bf, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：运动障碍;神经遗传;癫痫 经验分享：30 Sep 2022 Article accepted for publication. 25 Sep 2022 Review of Review Editor 3 finalized. 22 Sep 2022 re-submitted manuscript. You posted new comments. 21 Sep 2022 Reviewer 3 posted new comments. 20 Sep 2022 You posted new comments. 15 Sep 2022 Reviewer 3 posted new comments. 10 Sep 2022 re-submitted manuscript. 02 Aug 2022 submitted manuscript. 审稿人1直接拒稿，审稿人2建议修改后同意，审稿人3建议修改； 处理速度可以，比较及时，审稿意见也没有很为难，算比较顺利了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bf795518468, createdName=darkpigx, createdTime=Mon Oct 03 00:00:49 CST 2022, time=2022-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200098, encodeId=b1ef1200098b8, content=刚开始两个都同意了，修回后有一个拒，还有戏吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2fbe5639152, createdName=ms8000000759319128, createdTime=Mon Mar 07 00:18:28 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237910, encodeId=9e79123e91062, content=可以几个第一几个通讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dde62288731, createdName=121dfe5cm15暂无昵称, createdTime=Wed Aug 10 20:39:26 CST 2022, time=2022-08-10, status=1, ipAttribution=)]

2022-08-10 121dfe5cm15暂无昵称

可以几个第一几个通讯

64 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务